Furthermore, immunohistochemical (IHC) analysis of breast cancer samples with the ROCK1 and ROCK2 autophosphorylation site antibodies revealed that nuclear ROCK2 activation was associated with increased metastasis and poor patient outcomes [16]. This evidence concerns the gene ROCK2 and breast carcinoma.